• Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World
Newsy Today
news of today
Home - diabetes - Page 12
Tag:

diabetes

Health

A wearable optical system for glucose detection

by Chief Editor February 15, 2026
written by Chief Editor

The Future of Diabetes Management: From Invasive Tests to Sweat-Sensing Smartwatches

For millions worldwide living with diabetes, frequent glucose monitoring is a daily necessity. Traditionally, this has meant finger pricks and often, uncomfortable and potentially irritating invasive sensors. But a new era of diabetes management is dawning, driven by advancements in nanotechnology and wearable technology. Researchers are now successfully harnessing the power of sweat – a readily available biofluid – to track glucose levels in real-time, non-invasively.

Nanotechnology and the Rise of Sweat-Based Glucose Monitoring

The core of this revolution lies in the development of highly sensitive sensors capable of detecting minute glucose concentrations in sweat. Recent breakthroughs, as reported on February 12, 2026, utilize plasmonic nanopillar sensors coated with silver. These sensors, when exposed to glucose in sweat, undergo measurable changes in light reflection. This innovative approach avoids the need for enzymes or fluorescent labels, paving the way for simpler, more reliable and long-term monitoring solutions.

The key to this sensitivity is the use of silver, which allows for sharper plasmonic responses and a lower detection limit – as low as ~22 μmol/L – well within the range of glucose levels found in human sweat. This is a significant improvement over previous technologies and addresses a major challenge in sweat-based glucose monitoring: the typically low concentration of glucose in sweat compared to blood (10-100 times lower).

Wearable Technology: Integrating Sensors into Everyday Life

The true potential of these sensors is unlocked when integrated into wearable devices. Researchers have successfully created a prototype optical watch that incorporates the nanopillar sensor, a compact LED, a photodiode, and Bluetooth connectivity. This allows for real-time signal acquisition and wireless data transmission to a smartphone, providing users with continuous glucose readings without the need for invasive procedures.

This integration represents a significant step towards a “lab-on-a-watch” concept, where a single wearable device can monitor multiple biomarkers, not just glucose. The modular design of the platform allows for adaptation to detect other sweat-based indicators, such as lactate, electrolytes, or even stress-related metabolites.

Beyond Diabetes: Expanding the Scope of Sweat Sensing

While the initial focus is on diabetes management, the implications of this technology extend far beyond. Continuous, non-invasive monitoring of various biomarkers in sweat could revolutionize preventative healthcare and personalized medicine. Imagine athletes tracking their hydration levels and electrolyte balance in real-time, or individuals monitoring their stress levels throughout the day.

The ability to detect a wide range of biomarkers in sweat opens up possibilities for early disease detection, personalized fitness tracking, and even environmental monitoring. The simplicity and accessibility of sweat collection make it an ideal biofluid for widespread health monitoring applications.

Challenges and Future Directions

Despite the promising advancements, challenges remain. Ensuring the accuracy and reliability of sweat-based glucose monitoring in diverse environmental conditions and across different individuals is crucial. Further clinical validation and system integration, including automated sweat stimulation and microfluidic sampling, are necessary to refine the technology and prepare it for widespread adoption.

Researchers are similarly exploring ways to improve the longevity and durability of the sensors, as well as reduce the power consumption of the wearable devices. The goal is to create a comfortable, convenient, and affordable solution that can seamlessly integrate into people’s daily lives.

Frequently Asked Questions

Q: How does this technology differ from existing continuous glucose monitors (CGMs)?
A: Most CGMs rely on invasive sensors inserted under the skin. This new technology uses sweat, offering a non-invasive alternative.

Q: Is sweat glucose level a reliable indicator of blood glucose level?
A: Sweat glucose levels are correlated with blood glucose levels, although typically lower in concentration. The new sensors are designed to detect these low concentrations accurately.

Q: When will this technology be available to the public?
A: While the technology is promising, further clinical trials and regulatory approvals are needed before it becomes widely available.

Q: Can this technology be used for more than just glucose monitoring?
A: Yes, the platform can be adapted to detect other biomarkers in sweat, such as lactate and electrolytes.

Did you know? Silver nanoparticles possess antimicrobial properties, which could be particularly beneficial for diabetes patients who are prone to infections.

Pro Tip: Maintaining proper hydration is crucial for accurate sweat-based biomarker analysis. Ensure adequate fluid intake throughout the day.

Explore more about the latest advancements in nanotechnology and wearable health sensors. Share your thoughts and experiences in the comments below!

February 15, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Diabetic nephropathy shows severe biochemical abnormalities

by Chief Editor February 14, 2026
written by Chief Editor

Diabetic Nephropathy: Unraveling Biochemical Abnormalities and Future Trends

Chronic diabetes mellitus is increasingly recognized not just for its impact on blood sugar, but for its far-reaching consequences on multiple organ systems. A recent study highlights the complex biochemical disturbances associated with diabetic nephropathy (DNp), offering valuable insights into the disease’s progression and potential future diagnostic and therapeutic strategies.

The Biochemical Fingerprint of Diabetic Nephropathy

Researchers conducted a prospective case-control study involving 200 participants, categorized into groups with diabetic nephropathy (DNp), diabetes control (DC), nephropathy control (NC), and healthy controls. The findings revealed a distinct biochemical profile for each group. Notably, individuals with DNp exhibited significantly elevated fasting glucose (178.75 ± 61 mg/dL), glycated hemoglobin (8.13 ± 1.7%), creatinine (5.67 ± 1.8 mg/dL), and blood urea nitrogen (72.02 ± 22.8 mg/dL). These results underscore the strong link between poor glycemic control and impaired kidney function in DNp.

Inflammation and Lipid Profiles: Key Differentiators

Beyond glucose and kidney function markers, the study identified variations in inflammatory and lipid profiles. The nephropathy control (NC) group showed elevated levels of C-reactive protein (CRP) and lactate dehydrogenase (LDH), suggesting an inflammatory component. Interestingly, the diabetes control (DC) group displayed the most pronounced dyslipidemia, with elevated triglycerides, very low-density lipoprotein (VLDL), low-density lipoprotein (LDL), and cholesterol. This suggests that while DNp is characterized by kidney damage, DC may present with a more significant cardiovascular risk profile.

Future Trends in Diabetic Nephropathy Management

The detailed biochemical analysis presented in this study points towards several potential future trends in the management of diabetic nephropathy. A more personalized approach, focusing on individual biochemical profiles, could optimize treatment strategies.

Precision Medicine and Biomarker Discovery

The distinct biochemical signatures observed in each group suggest that precision medicine approaches could be highly beneficial. Identifying specific biomarkers – beyond traditional measures like creatinine – could allow for earlier diagnosis and more targeted interventions. For example, monitoring CRP and LDH levels might help identify individuals at risk of developing nephropathy, even before significant kidney damage occurs. Further research is needed to validate these biomarkers and establish their clinical utility.

Novel Therapeutic Targets

The study’s findings also highlight potential new therapeutic targets. Given the role of inflammation in the NC group, therapies aimed at reducing inflammation could be beneficial. Similarly, addressing dyslipidemia in the DC group could mitigate cardiovascular risk. Current research is exploring the use of SGLT2 inhibitors and GLP-1 receptor agonists, which have shown promise in both glycemic control and cardiovascular protection in patients with diabetes. [1]

Remote Monitoring and Digital Health

Advances in remote monitoring technologies and digital health solutions could play a crucial role in managing diabetic nephropathy. Wearable sensors and smartphone apps could track glucose levels, blood pressure, and other key parameters, providing real-time data to healthcare providers. This would enable more proactive interventions and personalized care plans.

Understanding the Link Between Diabetes and Kidney Disease

Diabetic nephropathy is a serious complication affecting approximately one-third of individuals with diabetes in the United States. [3] It develops as high blood sugar levels damage the filtering units of the kidneys, called nephrons. [5] Over time, this damage can lead to kidney failure, requiring dialysis or a kidney transplant. Poor glycemic control, uncontrolled hypertension, obesity, smoking, and a family history of kidney disease are all significant risk factors. [1]

FAQ

Q: What are the early signs of diabetic nephropathy?
A: Often, there are no noticeable symptoms in the early stages. As the condition progresses, symptoms may include swelling in the feet and ankles, changes in urination, nausea, and fatigue. [5]

Q: Can diabetic nephropathy be prevented?
A: While not always preventable, managing blood sugar levels, controlling blood pressure, and adopting a healthy lifestyle can significantly reduce the risk.

Q: Is diabetic nephropathy the same as diabetic kidney disease?
A: Yes, the terms are often used interchangeably. [3]

Q: What is the role of hyperglycemia in diabetic nephropathy?
A: Hyperglycemia, or high blood sugar, is a primary driver of diabetic nephropathy, leading to damage within the kidneys. [4]

Did you know? Early detection and management of diabetic nephropathy can significantly leisurely its progression and improve long-term outcomes.

Pro Tip: Regularly monitor your blood glucose and blood pressure, and work closely with your healthcare team to manage your diabetes effectively.

This research underscores the importance of a comprehensive approach to diabetes management, focusing not only on glycemic control but also on addressing inflammation, lipid profiles, and other biochemical abnormalities. Continued research and innovation will be crucial in developing more effective strategies to prevent and treat this debilitating condition.

Explore further: Learn more about diabetes management and kidney health on the Cleveland Clinic website: Cleveland Clinic – Diabetic Nephropathy

February 14, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Magnesium lower fasting blood sugar in older adults

by Chief Editor February 13, 2026
written by Chief Editor

Can Magnesium Be the Missing Link in Preventing Type 2 Diabetes?

A new study published in Frontiers in Nutrition suggests a potential role for magnesium supplementation in managing blood sugar levels, particularly in older adults with deficiencies. Whereas not a standalone cure, the research highlights magnesium as a modifiable risk factor in the progression from prediabetes to type 2 diabetes.

The Growing Concern of Prediabetes

Prediabetes, characterized by elevated blood glucose levels that haven’t yet reached diabetic thresholds, is a significant public health concern. Without intervention, it frequently leads to type 2 diabetes. Identifying effective preventative strategies is crucial, and emerging research points to the importance of nutritional status.

Magnesium’s Role in Glucose Metabolism

Magnesium is a vital mineral involved in numerous bodily functions, including glucose metabolism and insulin signaling. Deficiency, common among older adults due to reduced nutrient absorption, has been linked to impaired glucose control and insulin resistance. The recent study focused on whether correcting this deficiency could improve glycemic control.

Study Details: A Focused Approach

Researchers conducted a randomized controlled trial involving 71 older Chinese adults with both prediabetes and magnesium deficiency. Participants received either 360mg of magnesium oxide daily or a placebo for 16 weeks. The primary outcome measured was the change in fasting plasma glucose (FPG).

Modest Improvements in Fasting Glucose

The results showed that magnesium supplementation led to a statistically significant increase in serum magnesium levels and a modest reduction in fasting glucose – an adjusted mean difference of -0.5 mmol/L compared to the placebo group. However, other markers of glycemic control, such as HbA1c, did not demonstrate significant changes, suggesting the effect on overall glucose management was limited within the study’s timeframe.

The study authors emphasize that the observed benefits were most pronounced in individuals who were initially magnesium deficient. This suggests that supplementation is most effective when addressing an existing deficiency.

Beyond Glucose: Exploring Metabolomic Changes

Preliminary metabolomic analysis revealed changes in 52 metabolites associated with magnesium supplementation, hinting at potential impacts on lipid metabolism and insulin resistance. However, researchers caution that these findings are hypothesis-generating and require further investigation.

Limitations and Future Research Directions

The study, while well-designed, had limitations. The relatively small sample size limited statistical power. The use of fasting glucose as the primary endpoint, rather than more dynamic measures like oral glucose tolerance tests, may have missed some nuances of the intervention’s effect. The bioavailability of magnesium oxide, the form used in the study, is lower than other forms like citrate or glycinate.

Larger, longer-term trials are needed to confirm these findings and explore the potential benefits of different magnesium formulations. Future research should also investigate the optimal dosage and duration of supplementation for maximizing glycemic control.

What Does This Mean for the Future of Diabetes Prevention?

The study reinforces the idea that addressing micronutrient deficiencies could be a valuable component of a comprehensive diabetes prevention strategy. It’s unlikely that magnesium supplementation alone will prevent type 2 diabetes, but it may be a helpful adjunct to lifestyle interventions like diet and exercise, particularly for those identified as magnesium deficient.

The Rise of Personalized Nutrition

This research aligns with the growing trend towards personalized nutrition. Rather than a one-size-fits-all approach, future diabetes prevention strategies may increasingly focus on identifying individual nutrient deficiencies and tailoring interventions accordingly. Simple blood tests to assess magnesium status could become a routine part of prediabetes screening.

Metabolomics: A Window into Metabolic Health

The use of metabolomics in this study offers a glimpse into the potential of this technology for understanding the complex interplay between nutrients and metabolic processes. As metabolomic analysis becomes more accessible and affordable, it could provide valuable insights into individual responses to dietary interventions.

Focus on Bioavailability and Formulation

The limitations of magnesium oxide bioavailability highlight the importance of considering nutrient formulation. Future research and consumer products may prioritize more bioavailable forms of magnesium, such as citrate, glycinate, or threonate, to maximize absorption and efficacy.

FAQ

Q: Who should consider getting their magnesium levels checked?
A: Older adults, individuals with prediabetes, and those experiencing symptoms of magnesium deficiency (muscle cramps, fatigue, irregular heartbeat) should discuss testing with their healthcare provider.

Q: Is magnesium oxide the best form of magnesium supplement?
A: No, magnesium oxide has lower bioavailability than other forms like citrate, glycinate, and threonate.

Q: Can magnesium supplementation replace a healthy diet and exercise?
A: No. Magnesium supplementation is best viewed as a potential adjunct to a healthy lifestyle, not a replacement for it.

Q: How long does it take to see results from magnesium supplementation?
A: The study showed effects after 16 weeks, but individual responses may vary. It’s important to work with a healthcare professional to monitor progress.

Did you know? Approximately 60% of adults don’t meet the recommended daily allowance for magnesium.

Pro Tip: Include magnesium-rich foods in your diet, such as leafy green vegetables, nuts, seeds, and whole grains.

Want to learn more about preventing type 2 diabetes? Explore our other articles on nutrition and lifestyle interventions.

February 13, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Semaglutide lowers cardiovascular events even without major weight loss, researchers report

by Chief Editor February 12, 2026
written by Chief Editor

Semaglutide’s Expanding Role: Beyond Weight Loss to Comprehensive Cardiometabolic Care

Recent findings from the SELECT trial, published in The Lancet, are reshaping the understanding of semaglutide and other GLP-1 receptor agonists (GLP-1RAs). The study demonstrates that the cardiovascular benefits of semaglutide aren’t solely tied to weight loss, suggesting a broader impact on cardiometabolic health. This shift in perspective has significant implications for how clinicians approach the prevention and management of cardiovascular disease, particularly in individuals with obesity but without diabetes.

The SELECT Trial: A Paradigm Shift

The SELECT trial specifically enrolled individuals with established cardiovascular disease and obesity, but without type 2 diabetes. This was a crucial design element, allowing researchers to isolate the cardiovascular effects of semaglutide independent of glucose-lowering mechanisms. The trial showed a 20% reduction in major adverse cardiovascular events (MACE) – encompassing cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke – with semaglutide treatment. Importantly, this benefit was consistent across all baseline levels of weight and waist circumference.

Waist Circumference: A Key Indicator

Although overall weight loss didn’t directly correlate with the magnitude of cardiovascular benefit, changes in waist circumference did. The study found that reductions in waist circumference accounted for approximately one-third of semaglutide’s protective effect. This highlights the importance of visceral adiposity – fat stored around the abdominal organs – as a key driver of cardiovascular risk. Lower baseline waist circumference was also associated with lower MACE risk in both the semaglutide and placebo groups, reinforcing its significance as a risk marker.

Unpacking the Mechanisms: Beyond the Scale

The consistent cardiovascular benefits observed regardless of weight loss suggest that semaglutide impacts heart health through mechanisms beyond simply reducing body mass. Researchers hypothesize these may include anti-inflammatory effects, improvements in endothelial function (the lining of blood vessels), beneficial changes in blood pressure and lipid profiles, and even direct effects on the nervous system. These mechanisms are currently under investigation.

GLP-1RAs: Evolving from Diabetes Drugs to Cardiometabolic Therapies

Originally developed for type 2 diabetes, GLP-1RAs like semaglutide have demonstrated benefits in weight management and cardiovascular risk reduction. The SELECT trial solidifies the argument for repositioning these drugs as cardiometabolic therapies, applicable to a broader population than previously thought. This could lead to expanded prescribing guidelines and increased access for individuals at risk of cardiovascular disease, even in the absence of diabetes.

Future Trends and Implications

The findings from SELECT are likely to spur several key developments in the coming years:

  • Personalized Medicine: A greater emphasis on individual risk factors, including baseline adiposity measurements, to tailor GLP-1RA therapy.
  • Expanded Indications: Potential for regulatory approval of GLP-1RAs for primary and secondary prevention of cardiovascular events in individuals with obesity.
  • Combination Therapies: Exploration of combining GLP-1RAs with other cardiovascular medications to achieve synergistic benefits.
  • Long-Term Studies: Continued follow-up of patients in trials like SELECT-LIFE to assess the durability of cardiovascular benefits and identify potential long-term effects.
  • Focus on Visceral Fat: Increased attention to strategies for reducing visceral adiposity, including lifestyle interventions and targeted therapies.

FAQ

Q: Does this mean I should immediately start taking semaglutide?
A: Not necessarily. Semaglutide is a prescription medication with potential side effects. Discuss your individual risk factors and treatment options with your healthcare provider.

Q: Is weight loss still important for heart health?
A: Yes, weight loss remains an important component of a heart-healthy lifestyle. However, these findings suggest that the benefits of semaglutide extend beyond weight reduction.

Q: What is visceral fat and why is it so harmful?
A: Visceral fat is fat stored deep within the abdomen, surrounding the organs. It’s metabolically active and releases hormones and inflammatory substances that contribute to cardiovascular disease.

Q: Are there any side effects associated with semaglutide?
A: Common side effects can include nausea, vomiting, diarrhea, and constipation. More serious side effects are rare but possible. Your doctor will discuss potential risks and benefits with you.

Did you know? The SELECT trial included over 17,600 participants across 41 countries, making it one of the largest and most comprehensive studies of its kind.

Pro Tip: Focus on a holistic approach to heart health, including a balanced diet, regular exercise, stress management, and adequate sleep, in addition to any prescribed medications.

Want to learn more about the latest advancements in cardiovascular health? Explore our other articles or subscribe to our newsletter for regular updates.

February 12, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Tirzepatide shows dual benefits in sleep apnea trial improving metabolism and reducing inflammation

by Chief Editor February 10, 2026
written by Chief Editor

Tirzepatide: A New Approach to Tackling Sleep Apnea and Cardiometabolic Risk?

Recent findings from the SURMOUNT-OSA trial, published in Nature Medicine, suggest a potentially groundbreaking shift in how we manage the complex interplay between obstructive sleep apnea (OSA), obesity, and cardiometabolic health. The study highlights the significant benefits of tirzepatide, a dual GIP and GLP-1 receptor agonist, not just for weight loss, but also for directly improving sleep-disordered breathing and reducing associated health risks.

The Intertwined Challenges of OSA and Cardiometabolic Disease

Obstructive sleep apnea, a condition where breathing repeatedly stops and starts during sleep, is strongly linked to obesity and a host of cardiometabolic problems. These include high blood pressure, inflammation, insulin resistance, and increased risk of heart disease. Traditionally, continuous positive airway pressure (CPAP) therapy has been the first-line treatment for OSA, but adherence can be challenging for many patients.

While weight loss is a known factor in improving OSA severity, previous pharmacological interventions have often fallen short. Tirzepatide, however, appears to offer a more comprehensive solution by addressing both weight and the underlying breathing issues.

SURMOUNT-OSA: Key Findings and Mechanisms

The SURMOUNT-OSA program involved two phase 3 clinical trials with nearly 470 participants with obesity and moderate-to-severe OSA. Participants were either unwilling or unable to leverage CPAP (Study 1) or were already successful CPAP users (Study 2). The results demonstrated that tirzepatide led to significant improvements in several key cardiometabolic risk factors compared to placebo.

Specifically, tirzepatide was associated with reductions in systolic blood pressure (approximately -7.9 mmHg in Study 1 and -4.3 mmHg in Study 2), inflammation (measured by high-sensitivity C-reactive protein or hsCRP), and insulin resistance (assessed using the Homeostatic Model Assessment for Insulin Resistance or HOMA-IR). Triglyceride levels also decreased by around 32% in both trials.

Importantly, mediation analyses revealed that these benefits weren’t solely due to weight loss. Improvements in OSA metrics – like the Apnea–Hypopnea Index (AHI) and sleep apnea-specific hypoxic burden – independently contributed to the observed improvements in inflammation, insulin resistance, and triglycerides. This suggests that tirzepatide has a dual action, directly impacting both metabolic and respiratory health.

Beyond Weight Loss: The Potential for Integrated Treatment

The SURMOUNT-OSA findings underscore the importance of a holistic approach to OSA treatment. Simply addressing weight loss may not be enough to fully mitigate cardiometabolic risk. Targeting sleep-disordered breathing directly, alongside weight management, appears to yield more substantial benefits.

This could lead to a paradigm shift in clinical practice, where medications like tirzepatide are considered as part of an integrated treatment plan for patients with both obesity and moderate-to-severe OSA. However, researchers emphasize that more long-term data are needed to confirm these benefits and assess the impact on cardiovascular outcomes.

Limitations and Future Directions

The SURMOUNT-OSA trial had certain limitations. It excluded individuals with mild OSA, diabetes, or lower body mass index ranges. The study wasn’t designed to evaluate long-term cardiovascular events or mortality. Future research should focus on addressing these gaps and determining whether tirzepatide can translate into sustained improvements in cardiovascular health.

Frequently Asked Questions

Q: What is tirzepatide?
A: Tirzepatide is a medication that activates both GIP and GLP-1 receptors, leading to improved blood sugar control and weight loss.

Q: What is the Apnea–Hypopnea Index (AHI)?
A: The AHI measures the number of apneas (complete pauses in breathing) and hypopneas (shallow breaths) that occur per hour of sleep.

Q: Is tirzepatide a replacement for CPAP therapy?
A: The study suggests tirzepatide can be a valuable addition to treatment, but it doesn’t necessarily replace CPAP, especially for those who tolerate it well.

Q: Who was included in the SURMOUNT-OSA trial?
A: The trial included 469 adults with obesity and moderate-to-severe obstructive sleep apnea.

Q: What were the key cardiometabolic improvements observed?
A: Improvements included reductions in blood pressure, inflammation, insulin resistance, and triglyceride levels.

Pro Tip: Discuss with your healthcare provider whether tirzepatide might be a suitable treatment option for you, considering your individual health profile and risk factors.

Stay informed about the latest advancements in sleep apnea and cardiometabolic health by exploring our other articles on diabetes and cardiovascular disease.

Want to learn more? Share your thoughts and questions in the comments below!

February 10, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Can the artificial sweeteners in diet soda lead to health complications?

by Chief Editor February 7, 2026
written by Chief Editor

The Evolving Landscape of Diet Sodas: From Diabetic Aid to Dementia Concerns

Diet sodas, initially conceived as a lifeline for individuals managing diabetes, have undergone a dramatic transformation in public perception and scientific scrutiny. What began in the 1950s with Kirsch Bottling Company’s “No-Cal” – a groundbreaking beverage offering a sugar-free alternative – has evolved into a multi-billion dollar industry facing increasing questions about its long-term health effects.

The Genesis of Sugar-Free: A Need for Alternatives

Hyman Kirsch, a Russian immigrant and founder of Kirsch Bottling in Brooklyn, Novel York, recognized a critical gap in the beverage market. As a vice president for the Jewish Sanitarium for Chronic Diseases, he understood the challenges faced by diabetic patients restricted from consuming sugary drinks. This led to the development of No-Cal in 1952, utilizing artificial sweeteners to provide a palatable, non-alcoholic sweet beverage. Royal Crown Cola followed suit in 1958 with Diet Rite, further expanding the availability of diet soda options.

The Rise of Artificial Sweeteners and Regulatory Scrutiny

The core of diet soda’s appeal lies in its use of artificial sweeteners. The Food and Drug Administration (FDA) currently approves several sugar substitutes, including acesulfame potassium, aspartame, saccharin and sucralose. These compounds deliver intense sweetness without the caloric impact of sugar. However, the safety and long-term effects of these sweeteners have been a subject of ongoing debate and research.

Emerging Concerns: Cognitive Decline and Dementia Risk

Recent studies are raising concerns about the potential link between diet soda consumption and cognitive decline. Research suggests that individuals who consume diet soda daily may face an increased risk of dementia. Specifically, one study found that each additional diet soda consumed per day was linked to a 34% increase in dementia risk, with those drinking more than one daily experiencing approximately four times the risk compared to those consuming one or fewer.

Interestingly, the impact appears to be more pronounced in individuals under the age of 60. The study revealed faster declines in verbal fluency and overall cognition in this age group, a finding not replicated in those over 60.

Beyond Dementia: Potential Health Risks

The potential health implications extend beyond cognitive function. Consuming even one diet soda a day has been linked to negative health outcomes. Research indicates a possible decline in memory and recall abilities among heavy consumers of artificial sweeteners. Experts caution against assuming that low and no-calorie sweeteners are inherently beneficial, given their widespread presence in products marketed as “healthier” alternatives.

The Mediterranean Diet as a Protective Factor

As concerns surrounding diet soda consumption grow, health professionals are increasingly emphasizing the benefits of a holistic dietary approach. Adherence to a Mediterranean-style diet, rich in water, tea, and coffee, has been consistently shown to reduce the risk of cognitive impairment, dementia, stroke, and myocardial infarction.

Future Trends: A Shift Towards Natural Sweeteners and Holistic Wellness

The future of the beverage industry likely lies in a move away from artificial sweeteners and towards more natural alternatives. Luo han guo (Monk Fruit) and purified stevia leaf extracts are gaining popularity as potential sugar substitutes. However, even these natural options require careful consideration and further research.

Clinicians are advocating for reduced reliance on artificially sweetened beverages, promoting water and unsweetened alternatives, and closely monitoring metabolic risk factors in heavy diet soda consumers. The emphasis is shifting towards a broader focus on holistic wellness, recognizing that a healthy lifestyle encompasses more than just calorie counting.

FAQ

  • When was the first diet soda introduced?
  • The first diet soda, No-Cal, was introduced in 1952 by Kirsch Bottling Company in Brooklyn, New York.

  • What was the original purpose of diet soda?
  • Diet soda was originally developed to provide a refreshing beverage option for individuals with diabetes who needed to avoid sugar.

  • Are artificial sweeteners safe?
  • The FDA approves several artificial sweeteners for use in food and beverages, but ongoing research continues to evaluate their long-term health effects.

  • Is there a link between diet soda and dementia?
  • Recent studies suggest a potential link between daily diet soda consumption and an increased risk of dementia, particularly in individuals under the age of 60.

Pro Tip: Prioritize water intake throughout the day. Infuse water with fruits or herbs for added flavor without the artificial sweeteners.

Do you have questions about diet soda and its impact on health? Share your thoughts in the comments below!

February 7, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Study Finds Higher Insulin Levels May Mean Earlier, Longer Hot Flashes

by Chief Editor February 4, 2026
written by Chief Editor

The Emerging Link Between Insulin & Menopause: A New Era of Personalized Treatment?

For decades, menopause has been largely understood through the lens of hormonal shifts. But a growing body of research, highlighted by a recent study in the Journal of Clinical Endocrinology & Metabolism, is revealing a crucial piece of the puzzle: metabolic health. Specifically, higher fasting insulin levels appear to be linked to earlier, more intense vasomotor symptoms (VMS) – those familiar hot flashes and night sweats – experienced by women during perimenopause and beyond.

Decoding the Insulin-Menopause Connection

The study, which followed approximately 700 American women aged 42-52 for over a decade, found a clear correlation. Women with higher insulin levels at age 47 experienced not only earlier onset of VMS but also a longer duration of these symptoms. This isn’t simply about weight; while body mass index (BMI) also played a role, insulin levels appeared to have an independent impact. This suggests a more complex interplay than previously understood.

“We’ve known for some time that metabolic syndrome – a cluster of conditions including high blood pressure, high blood sugar, unhealthy cholesterol levels, and excess abdominal fat – is more prevalent after menopause,” explains Dr. Alyssa Dweck, a board-certified OB-GYN and Chief Medical Officer of Bonafide Health. “This study helps solidify the idea that metabolic dysfunction isn’t just a *result* of hormonal changes, but potentially a *driver* of symptom severity.”

Beyond Hot Flashes: The Wider Metabolic Impact

The implications extend beyond just VMS. The research also noted a rise in testosterone levels during the menopausal transition in women with higher insulin. Elevated testosterone can contribute to other symptoms like acne, hair loss, and changes in libido. Furthermore, the link between insulin resistance and increased risk of type 2 diabetes is well-established. Midlife represents a critical window for diabetes prevention, and understanding this connection is paramount.

Did you know? Women are often diagnosed with type 2 diabetes *after* menopause, but the underlying insulin resistance can begin years earlier, during perimenopause.

The Rise of Predictive Testing & Personalized Interventions

The most exciting prospect stemming from this research is the potential for predictive testing. Imagine a simple blood test, administered during perimenopause, that could identify women at higher risk of severe VMS. This would allow for proactive interventions, tailored to individual metabolic profiles.

“Currently, menopause management is largely reactive – women seek help *after* symptoms begin,” says Faria Athar, the study’s lead author. “If we could identify those at risk beforehand, we could implement lifestyle changes or even consider early medical interventions to mitigate the impact.”

Lifestyle as Medicine: The Power of Proactive Choices

While the idea of a predictive test is promising, the current takeaway is clear: lifestyle matters. Studies consistently demonstrate that consistent exercise, particularly strength training, and a nutritious diet – like the Mediterranean diet – can significantly improve insulin sensitivity and overall metabolic health.

Pro Tip: Focus on incorporating protein and fiber into every meal to help stabilize blood sugar levels and reduce insulin spikes. Prioritize whole, unprocessed foods over refined carbohydrates and sugary drinks.

This isn’t about achieving a specific weight; it’s about optimizing metabolic function. Even modest improvements in insulin sensitivity can translate to noticeable relief from perimenopause and menopause symptoms.

The Future of Menopause Care: A Holistic Approach

The future of menopause care is likely to be far more holistic, integrating hormonal therapies with metabolic assessments and personalized lifestyle recommendations. We’re moving away from a one-size-fits-all approach towards a model that recognizes the unique metabolic fingerprint of each woman.

Emerging technologies, such as continuous glucose monitoring (CGM), traditionally used by people with diabetes, are also gaining traction among women seeking to understand their metabolic response to different foods and activities. This data-driven approach empowers women to make informed choices about their health.

What About Medications?

While lifestyle interventions are foundational, medications may also play a role, particularly for women with significant insulin resistance. Metformin, a drug commonly used to treat type 2 diabetes, is being investigated for its potential to reduce VMS severity. However, more research is needed to determine its long-term safety and efficacy in this context.

Frequently Asked Questions (FAQ)

  • Q: Does this mean all women with high insulin will experience severe menopause symptoms?
    A: Not necessarily. This study shows a *correlation*, not causation. Other factors, such as genetics, ethnicity, and socioeconomic status, also play a role.
  • Q: Can I lower my insulin levels naturally?
    A: Yes! Regular exercise, a healthy diet, stress management, and adequate sleep can all help improve insulin sensitivity.
  • Q: Is there a specific test I can ask my doctor about?
    A: Talk to your doctor about getting your fasting insulin levels checked, along with a comprehensive metabolic panel.
  • Q: When is the best time to start focusing on metabolic health?
    A: Ideally, *before* perimenopause begins. However, it’s never too late to make positive changes.

This research marks a significant shift in our understanding of menopause. By recognizing the crucial link between metabolic health and symptom severity, we can empower women to take control of their health and navigate this transition with greater ease and well-being.

Want to learn more about managing menopause symptoms? Explore our comprehensive menopause resource center.

February 4, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Fasting Before Blood Tests: Why It’s Crucial for Accurate Results

by Chief Editor February 3, 2026
written by Chief Editor

The Hidden Impact of Breakfast: How Food Timing is Revolutionizing Health Testing

For years, we’ve been told to fast before blood tests. But a recent surge in awareness, fueled by medical professionals like Spanish traumatologist Inés Moreno (@latraumatologageek), is highlighting just how dramatically food intake can skew results. This isn’t just about inconvenience; it’s about accurate diagnoses and avoiding unnecessary medical interventions. But this is just the beginning. The future of health testing is moving beyond simply *avoiding* food, towards personalized protocols based on individual metabolic responses.

Beyond Glucose: The Ripple Effect of Eating on Bloodwork

The initial concern centers around glucose and insulin levels. As Moreno explains, even a simple breakfast can mimic the blood profile of someone with diabetes. However, the impact extends far beyond sugar. Triglycerides, a type of fat, spike after eating. Cholesterol levels fluctuate. Even markers of inflammation can be temporarily elevated due to the digestive process. This creates a complex picture that can lead to misinterpretations. A 2022 study published in the journal Clinical Chemistry and Laboratory Medicine demonstrated that even moderate food intake within 2-3 hours of a lipid panel test can increase triglyceride levels by up to 50%.

The Rise of Continuous Glucose Monitoring (CGM) and Personalized Fasting

The growing popularity of Continuous Glucose Monitoring (CGM), initially for diabetics, is driving a shift towards understanding individual metabolic responses. CGMs provide real-time data on glucose fluctuations, revealing how different foods and activities impact blood sugar levels. This data is empowering individuals to optimize their diets and lifestyles. Companies like Levels and Veri are leading this charge, offering CGMs paired with personalized insights. This granular data is also informing a move away from a “one-size-fits-all” fasting approach.

Instead of a standard 8-12 hour fast, we’re likely to see more labs offering tailored fasting protocols. Imagine a future where your doctor prescribes a 6-hour fast if your CGM data shows a rapid metabolic rate, or a 14-hour fast if your body processes food more slowly. This personalized approach will significantly improve the accuracy of test results.

The Impact on Preventative Healthcare and Early Disease Detection

More accurate blood tests have profound implications for preventative healthcare. Early detection of conditions like pre-diabetes, heart disease, and even certain cancers relies on identifying subtle changes in biomarkers. If those biomarkers are masked by recent food intake, critical warning signs could be missed. The ability to obtain truly baseline data will allow for earlier interventions and potentially prevent the progression of chronic diseases. A recent report by the CDC estimates that 38% of US adults have prediabetes, many of whom are undiagnosed. More accurate testing could significantly reduce this number.

The Role of AI and Machine Learning in Interpreting Bloodwork

The sheer volume of data generated by CGMs and advanced blood tests is overwhelming. Artificial intelligence (AI) and machine learning (ML) are poised to play a crucial role in analyzing this data and identifying patterns that would be impossible for humans to detect. AI algorithms can account for individual factors like age, gender, genetics, and lifestyle to provide a more nuanced interpretation of bloodwork. Several startups, including PathAI and Paige, are already using AI to improve the accuracy of pathology diagnoses, and similar applications are emerging in the field of blood analysis.

Future Trends: At-Home Testing and the “Digital Biomarker” Revolution

The trend towards at-home testing is accelerating, driven by convenience and affordability. Companies like LetsGetChecked and Everlywell offer a wide range of blood tests that can be performed in the comfort of your own home. However, ensuring accurate results with at-home testing requires even greater emphasis on proper fasting protocols and clear instructions.

Looking further ahead, we’re entering an era of “digital biomarkers” – physiological and behavioral data collected from wearable sensors and smartphones. This data, combined with traditional blood tests, will provide a holistic picture of an individual’s health status. For example, sleep patterns tracked by a smartwatch could be correlated with blood glucose levels to identify individuals at risk of insulin resistance. This integrated approach promises to revolutionize healthcare, moving from reactive treatment to proactive prevention.

Pro Tip: When scheduling a blood test, always confirm the specific fasting requirements with your doctor or the lab. Don’t assume a standard 12-hour fast is sufficient.

Frequently Asked Questions (FAQ)

  • How long do I need to fast before a blood test? Typically 8-12 hours, but always confirm with your doctor.
  • Can I drink water while fasting? Yes, water is generally allowed.
  • Does coffee affect blood test results? Black coffee is usually permitted, but avoid adding sugar or cream.
  • What happens if I accidentally eat before my blood test? Inform the lab technician. They may need to reschedule your appointment.
  • Are all blood tests affected by food? No, tests like complete blood count (CBC) usually don’t require fasting.

Did you know? The accuracy of blood tests can be affected by even seemingly minor factors like chewing gum or using mouthwash containing alcohol.

Want to learn more about optimizing your health through personalized testing? Explore our articles on Continuous Glucose Monitoring and the future of preventative medicine.

Share your experiences with fasting and blood tests in the comments below! What challenges have you faced, and what strategies have you found helpful?

February 3, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Can Diabetics Eat Chickoo Daily? Here’s What Experts Say

by Chief Editor February 3, 2026
written by Chief Editor

Chickoo & Diabetes: A Sweet Spot or a Risky Treat? Exploring the Future of Fruit & Blood Sugar Management

The humble chickoo, or sapota, has long been a beloved fruit for its creamy texture and delightful sweetness. But in an era increasingly focused on metabolic health, particularly for the millions living with diabetes, questions about its place in a healthy diet are growing. This isn’t just about chickoo; it’s a microcosm of a larger trend: a re-evaluation of how we understand fruit consumption in the context of blood sugar control. The future of this relationship will likely involve personalized nutrition, advanced monitoring, and a shift away from blanket recommendations.

The Nutritional Powerhouse Behind the Sweetness

Chickoo isn’t lacking in benefits. Rich in vitamins A, B, C, and E, alongside essential minerals like calcium, magnesium, potassium, and manganese, it’s a nutritional boost. Ayurvedic practitioners, as highlighted in recent reports, emphasize its heart-healthy properties and digestive aid. A 2021 study published in the Journal of Functional Foods demonstrated sapota’s potential to enhance gut microbiome diversity, a key factor in overall health. Its fibre content and antioxidants further contribute to well-being, supporting bone strength, eyesight, and even skin health. However, these benefits are weighed against its sugar content.

The Glycemic Load Dilemma: Why Caution is Key

The core concern revolves around chickoo’s glycemic index (GI) and glycemic load (GL). While the GI measures how quickly a food raises blood sugar, the GL considers both the GI and the amount of carbohydrate in a serving. Chickoo’s relatively high GL means it can cause a significant glucose spike, particularly problematic for individuals with diabetes or insulin resistance. This isn’t unique to chickoo. Many fruits, even those considered “healthy,” can impact blood sugar levels. The future will see a move towards understanding individual responses to different fruits, rather than simply categorizing them as “good” or “bad.”

Personalized Nutrition: The Rise of Continuous Glucose Monitoring (CGM)

One of the most significant trends shaping the future of fruit consumption for diabetics is the increasing accessibility of Continuous Glucose Monitoring (CGM) devices. Previously reserved for those on intensive insulin therapy, CGMs are becoming more mainstream. These devices provide real-time data on blood glucose levels, allowing individuals to see exactly how different foods – including fruits like chickoo – affect their bodies. Companies like Dexcom and Abbott are driving this innovation, with CGM adoption rates increasing by over 20% annually in the US (Source: Diabetes Technology & Therapeutics, 2023). This data empowers individuals to make informed choices and tailor their diets accordingly.

Pro Tip: Pairing fruit with protein and healthy fats can help mitigate blood sugar spikes. For example, a small portion of chickoo with a handful of almonds or a dollop of Greek yogurt can slow down glucose absorption.

Beyond Chickoo: The Broader Trend of Low-Glycemic Fruit Alternatives

The caution surrounding chickoo is prompting a search for lower-glycemic fruit alternatives. Guava, apples, berries (especially blueberries and raspberries), and citrus fruits are gaining popularity. These fruits generally have a lower GL and are rich in fibre, which helps regulate blood sugar. Furthermore, research is focusing on developing fruit varieties with naturally lower sugar content through selective breeding and genetic modification. Expect to see more “low-GI” fruit options appearing in supermarkets in the coming years.

The Role of Gut Health and Prebiotics

Emerging research highlights the crucial link between gut health and blood sugar control. Fruits like chickoo contain prebiotics – fibres that feed beneficial gut bacteria. A healthy gut microbiome can improve insulin sensitivity and reduce inflammation, potentially mitigating the negative effects of fruit sugars. However, the impact of prebiotics varies depending on individual gut composition. Personalized microbiome analysis, coupled with dietary recommendations, is likely to become a standard practice in diabetes management.

Allergies and Other Considerations

Beyond blood sugar, it’s important to remember that some individuals may experience allergic reactions to chickoo due to its latex and tannin content. Weight management is another factor; its calorie density means moderation is key for those watching their weight. These considerations reinforce the need for a holistic approach to dietary choices.

Reader Question: “I love chickoo, but I’m pre-diabetic. Can I ever enjoy it again?”

It’s possible, but moderation and monitoring are crucial. Work with a registered dietitian or healthcare provider to determine a safe portion size and monitor your blood glucose levels after consumption. Consider pairing it with protein and fat, and prioritize lower-glycemic fruits most of the time.

FAQ

  • Is chickoo good for diabetics? Generally, no. Its high sugar content can cause blood sugar spikes.
  • What fruits are best for diabetics? Berries, apples, guava, and citrus fruits are generally good choices.
  • Can I eat chickoo if my blood sugar is well-controlled? Small portions may be permissible under medical guidance.
  • What is glycemic load? It’s a measure of how much a food raises blood sugar, considering both the GI and carbohydrate content.
  • Does gut health affect blood sugar? Yes, a healthy gut microbiome can improve insulin sensitivity.

The future of fruit and diabetes isn’t about restriction, but about understanding. By leveraging technology like CGMs, embracing personalized nutrition, and prioritizing gut health, individuals can navigate the complexities of fruit consumption and enjoy a balanced, healthy diet.

Want to learn more about managing diabetes through diet? Explore our other articles on metabolic health or subscribe to our newsletter for the latest research and expert advice.

February 3, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Your next primary care doctor could be online only, accessed through an AI tool

by Chief Editor February 2, 2026
written by Chief Editor

The AI Doctor Will See You Now: Reshaping Primary Care in a Time of Crisis

Tammy MacDonald’s story, like that of millions of Americans, highlights a growing crisis: access to primary care is dwindling. The sudden loss of a physician can trigger a frustrating search, often met with months-long wait times. But increasingly, the answer isn’t another human doctor – it’s artificial intelligence. The rise of AI-powered platforms like Mass General Brigham’s Care Connect signals a fundamental shift in how healthcare is delivered, and it’s a trend poised to accelerate.

The Primary Care Provider Shortage: A National Emergency

The statistics are stark. Roughly 17% of U.S. adults lack a primary care physician, a number that’s climbing. Massachusetts, despite its reputation for medical excellence, is experiencing a particularly acute shortage. This isn’t simply a matter of inconvenience; it impacts preventative care, chronic disease management, and overall health outcomes. The Association of American Medical Colleges projects a shortage of up to 124,000 physicians by 2034, exacerbating the problem.

Why Are Doctors Leaving Primary Care?

The reasons are multifaceted. Burnout is rampant, fueled by increasing administrative burdens and complex patient cases. Financial disparities also play a significant role. Primary care physicians earn, on average, 30-50% less than specialists, despite often handling more patients and a wider range of issues. This financial imbalance discourages medical students from entering primary care, creating a vicious cycle.

AI as a Stopgap – and a Potential Solution

Hospitals and health networks are turning to AI not as a replacement for doctors, but as a force multiplier. Platforms like Care Connect utilize AI chatbots to triage patients, gather information about their symptoms, and even suggest preliminary diagnoses and treatment plans to physicians. This frees up doctors to focus on more complex cases and reduces administrative overhead. Beyond triage, AI is being deployed for tasks like medical note transcription, billing, and even analyzing diagnostic images.

Did you know? A recent study by Cedars-Sinai found that AI was slightly better than physicians at identifying critical red flags in patient cases, though physicians excelled at nuanced adjustments based on patient interaction.

Beyond Chatbots: The Expanding Role of AI in Healthcare

The future of AI in primary care extends far beyond symptom checkers. We’re seeing the development of:

  • Predictive Analytics: AI algorithms can analyze patient data to identify individuals at high risk for chronic diseases, allowing for proactive interventions.
  • Personalized Medicine: AI can tailor treatment plans based on a patient’s genetic makeup, lifestyle, and medical history.
  • Remote Patient Monitoring: Wearable sensors and AI-powered platforms can track vital signs and alert doctors to potential problems in real-time.
  • Automated Administrative Tasks: AI can streamline tasks like appointment scheduling, insurance pre-authorization, and claims processing.

K Health, the company behind the Care Connect platform, is partnering with major healthcare systems like Mayo Clinic and Cedars-Sinai, demonstrating the growing confidence in AI’s potential. Their CEO, Allon Bloch, argues that technology and AI are essential to solving America’s healthcare access and affordability challenges.

The Concerns and Challenges Ahead

Despite the promise, significant concerns remain. Critics worry about the potential for AI to miss subtle nuances in patient presentations, particularly those with complex or overlapping conditions. The “human touch” – the empathy, trust, and understanding built through long-term doctor-patient relationships – is difficult to replicate with AI. Furthermore, equitable access to technology and digital literacy are crucial considerations.

Pro Tip: When using AI-powered healthcare tools, always double-check information with a qualified medical professional and be prepared to provide detailed information about your medical history and symptoms.

Data Privacy and Security

The use of AI in healthcare raises serious data privacy and security concerns. Protecting sensitive patient information from breaches and misuse is paramount. Robust security measures and strict adherence to HIPAA regulations are essential.

The Hybrid Future: AI-Augmented, Not AI-Replaced

The most likely future isn’t one where AI replaces primary care physicians entirely. Instead, it’s a hybrid model where AI augments their capabilities, allowing them to provide more efficient, personalized, and accessible care. Doctors will leverage AI tools to streamline administrative tasks, analyze data, and make more informed decisions, while still maintaining the crucial human connection with their patients.

FAQ: AI and Your Healthcare

  • Is AI diagnosis accurate? AI can be accurate for common conditions, but it’s not a substitute for a doctor’s expertise, especially for complex cases.
  • Is my data safe with AI healthcare platforms? Reputable platforms employ robust security measures, but it’s important to understand their privacy policies.
  • Will AI lead to job losses for doctors? Most experts believe AI will change the role of doctors, not eliminate it. It will free them up to focus on more complex tasks.
  • Can AI replace the empathy of a human doctor? Currently, no. Empathy and the doctor-patient relationship remain crucial aspects of healthcare.

The Road Ahead: Investment and Integration

Mass General Brigham’s $400 million investment in primary care, including the Care Connect program, is a sign of things to come. However, simply throwing money at AI isn’t enough. Successful integration requires careful planning, robust training for healthcare professionals, and a commitment to addressing the underlying issues driving the primary care shortage – burnout, financial disparities, and administrative burdens.

What are your thoughts on the role of AI in healthcare? Share your opinions in the comments below!

Explore more articles on healthcare innovation | Subscribe to our newsletter for the latest updates

February 2, 2026 0 comments
0 FacebookTwitterPinterestEmail
Newer Posts
Older Posts

Recent Posts

  • China: Hormuz Strait Navigation Issues Must Be Handled Properly

    July 3, 2026
  • Mourners Weep as Ayatollah Khamenei’s Casket Is Displayed

    July 3, 2026
  • Hungarian Writer Krasznahorkai Declines National Artist Award

    July 3, 2026
  • Royals 2.0 Gym Opens New, Larger Holbeach Facility

    July 3, 2026
  • REDs in Ultra-Trail Running: Performance, Injury, and Health Risks

    July 3, 2026

Popular Posts

  • 1

    Maya Jama flaunts her taut midriff in a white crop top and denim jeans during holiday as she shares New York pub crawl story

    April 5, 2025
  • 2

    Saar-Unternehmen hoffen auf tiefgreifende Reformen

    March 26, 2025
  • 3

    Marta Daddato: vita e racconti tra YouTube e podcast

    April 7, 2025
  • 4

    Unlocking Success: Why the FPÖ Could Outperform Projections and Transform Austria’s Political Landscape

    April 26, 2025
  • 5

    Mecimapro Apologizes for DAY6 Concert Chaos: Understanding the Controversy

    May 6, 2025

Follow Me

Follow Me
  • Cookie Policy
  • CORRECTIONS POLICY
  • PRIVACY POLICY
  • TERMS OF SERVICE

© 2026 Newsy Today. All rights reserved.
For contact, advertising, copyright, issues email: [email protected]


Back To Top
Newsy Today
  • Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World